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Conclusion: Heritability of ultrasound plaque characteristics is high.
Summary: Only a few studies have even partially investigated genetic
determinants of carotid plaque characteristics. The San Antonio Family
Heart Study found moderate (23%-28%) heritability of the presence of
carotid plaques (Hunt KJ et al, Stroke 2002;33:2775-80). The Erasmus
Rucphen Family (ERF) study used a carotid plaque score to quantify
common carotid artery carotid bifurcation and internal carotid artery plaque
and found 28% heritability of the carotid plaque (Sayed-Tabatabaei FA et al,
Stroke 2005;36:2351-6). It is also known that underlying atherosclerotic
phenotypes associated with carotid plaque formation (intima-media thick-
ness, arterial stiffness) can also exhibit moderate heritability. However,
genetic determinants related directly to carotid plaque characteristics are
not clear. The authors sought to study the heritability of carotid plaque
characteristics in a twin population. Twin studies more reliably estimate rela-
tive contribution of genes to phenotypic traits than can be determined with
a “family study” design. There were 192 monozygotic and 83 dizygotic
adult twin pairs (age 49 6 15 years) from Italy, Hungary, and the United
States who underwent B-mode and color Doppler ultrasound imaging of
their bilateral common, internal, and external carotid arteries. Age-, sex-,
and country-adjusted heritability was 78% for the presence of carotid plaque
(95% conﬁdence interval [CI] 55%-90%), 74% for plaque echogenicity (95%
CI, 38%-87%), and 69% for plaque size (area in mm2 in longitudinal plane;
<50 percentile or >50 percentile; 95% CI, 16%-86%). Adjusted heritability
for plaque sidedness was 74% (95% CI, 25%-90%). Heritability was 74% for
plaque numerosity (95% CI, 26%-86%) and 68% (95% CI, 40%-84%) and
66% (95% CI, 32%-90%), respectively, for presence of plaque in the carotid
bulb and proximal internal carotid artery. No role for shared environmental
factors was found. The remaining variants (22%-34%) were attributed to
unique environmental factors. Controlling for relative covariates did not
change the results of the study signiﬁcantly.
Comment: This is the ﬁrst international twin population study to
investigate heritability of carotid plaque characteristics. Heritability of the
carotid plaque in this study is considerably higher than in previous studies,
with the inevitable corollary that the inﬂuence of unique environmental
factors on development of carotid plaque is actually moderate. Because
unshared environmental factors accounted for only a modest portion of vari-
ability in carotid plaque, the authors’ ﬁndings should stimulate a search for
genes responsible for the variability of carotid plaque in response to athero-
sclerotic risk factors.Current Prevalence of Abdominal Aortic Aneurysm in 70-Year-Old
Women
Svensjo S, Bjorck M, Wanhainen A. Br J Surg 2013;100:367-72.
Conclusion: Screening 70-year-old women who do not smoke is
likely to be ineffective in discovering abdominal aortic aneurysm (AAA).
Summary: Ultrasound screening of older men for AAA is an
evidence-based method to reduce aneurysm-related and all-cause mortality.
The only randomized study including women, however, demonstrated no
reduction in mortality with aortic aneurysm screening (Scott RA et al, Br
J Surg 2005;89:283-5). A modeling study, however, suggests screening
woman could be cost-effective given the observed higher rupture rates of
AAA in women and increased longevity among women compared with
men (Wanhainen A et al, J Vasc Surg 2006;43:908-14). The Society for
Vascular Surgery recommends aneurysm screening among older women
with a family history of AAA or who have smoked (Chaikof EL et al.
J Vasc Surg 2009;50(Suppl):S2-49). The U.S. Preventative Services Task
Force, however, found no evidence of beneﬁt in screening women, regard-
less of risk factors (U.S. Preventative Task Force, Ann Intern Med
2005;142:198-202). However, people also may be healthier now, and
with delayed aneurysm development, than at the time screening for AAAs
was ﬁrst evaluated. The aim of this study was therefore to determine the
prevalence of AAA and risk factors in a contemporary well-deﬁned popula-
tion of 70-year-old women. The study targeted 70-year-old women because
previous investigations suggested AAAs present later in life in women thanin men (Katz DJ et al, J Vasc Surg 1997;25:561-8). The 70-year-old
women were identiﬁed through the Swedish National Population Registry
in two neighboring counties of Uppsala and Dalarna and were invited to
a free ultrasound examination of the abdominal aorta. An aorta >30 mm
in diameter was deﬁned as an AAA. Of the 6925 women who were invited,
5140 (74.2%) accepted the invitation for screening and 19 AAAs (0.4%)
were detected (95% conﬁdence interval [CI], 0.2%-0.5%). In the invited
cohort, 12 women (0.2%; 95% CI, 0.1%-0.3%) had undergone previous
AAA repair (11) or had a known AAA under surveillance (one). The total
prevalence of AAA was therefore estimated at 0.5% (0.4%-0.7%). Of 19
women with screen-detected AAAs, 18 (95%) had a history of smoking
compared with a smoking history of 44.2% of those with a normal aorta
(odds ratio, 20.29; 95% CI, 2.7-152.65). Prevalence of AAA was 0.03%
(0%-0.1%) among never smokers, 0.4% (0.2%-0.8%) among former smokers,
and 2.1% (1.0%-3.7%) among current smokers.
Comment: People are getting healthier and engaging in less risky
behavior. In the current study, smoking was the only independent risk factor
for AAA. Previous studies have indicated higher rates among women for
smoking history, hypertension, elevated cholesterol, and coronary disease
than were found in the current study (Derubertis BG et al, J Vasc Surg
2007;46:630-7 and Lederle FA et al, J Vasc Surg 2001;34:122-6). In
Sweden, a 70-year-old woman is likely to live another 17 years. We also
know that at least in men, some people who initially screen negatively will
eventually die of a ruptured AAA. Therefore, although the data certainly
indicate screening for AAA among nonsmoking woman at age 70 is of no
beneﬁt, the value of targeted screening of an older woman who is still
smoking is potentially an open question. Given the low prevalence of aneu-
rysm in women, this question is unlikely to be answered without a study
randomizing at least 100,000 elderly women; a study so ponderous as to
be a logistic impossibility.Final Follow-up of the Multicentre Aneurysm Screening Study
(MASS) Randomized Trial of Abdominal Aortic Aneurysm Screening
Thompson SG, Ashton HA, Gao L, et al, on behalf of the Multicentre
Aneurysm Screening Study (MASS) Group. Br J Surg 2012;99:1649-56.
Conclusion: Screening for abdominal aortic aneurysms (AAA) results
in a reduction of all-cause mortality out to 13 years of follow-up.
Summary: The UK Multicenter Aneurysm Screening Study (MASS)
is the largest randomized trial of screening vs no screening of AAAs to
reduce aneurysm and all-cause mortality. Previous results from MASS
were published after 10 years of follow-up (Thompson SG et al, BMJ
2009;338;b2307). At that time, there was some increase in rupture of
AAA among those initially screened as normal. However, this increase
had no impact on overall proportionate AAA-related mortality. The 15-
year results of the UK Chichester trial suggested a possible substantial
increase in ruptured AAAs during follow-up (Ashton HA et al, Br J Surg
2007;94:696-701). Signiﬁcant numbers of AAA ruptures in those initially
screened as normal could result in a long-term reduction of beneﬁts in
AAA mortality implied by a normal initial screening study. This latest publi-
cation from the MASS trial investigators examined further follow-up in the
MASS trial participants with respect to potential beneﬁts of all-cause
mortality and late AAA rupture in those initially screened as normal. The
MASS trial was a population-based sample of men aged 65 to 74 years
who were randomized to an invitation for ultrasound screening (invited
group) for AAA or to a control group that was not offered screening.
Patients with an abdominal aorta >3 cm detected at the initial study under-
went surveillance and were offered surgery after predeﬁned criteria had been
met. Cause-speciﬁc mortality data were analyzed using Cox regression tech-
niques. The study enrolled 67,770 men. Over 13 years, 224 AAA-related
deaths occurred in the invited group and 381 in the control group. This
was a relative risk reduction of 42% in the invited group compared with
the control group (hazard ratio, 0.58; 95% conﬁdence interval, 0.49-
0.69). Relative risk reduction did not vary by baseline age or center, and
there was no evidence of an effect on other causes of death. There was an
overall reduction in all-cause mortality of 3% (1%-5%). Beneﬁt was greater
in earlier years of follow-up and decreased with longer follow-up, with
a risk reduction of 48% from randomization to 10 years and 20% from 10
to 14 years. During the 13-year interval, nonfatal AAA ruptures were halved1447
